SAIL Fusion conducted the first implantations of its novel BowTie SI Fusion System. BowTie is reported to be the first SI fusion system to be based on long-standing joint fusion principles established by the AO Foundation. The technology and surgical technique are designed to minimize tissue disruption, thoroughly prepare the joint and provide rigid fixation to enable true and robust arthrodesis.
The device features a novel bowtie shape and integrated iliac and sacral transfixing screws to maximize rigidity, as well as a proprietary porous structure and roughened surface technology to aid in osteointegration.
David Jansen, President & CEO of SAIL, commented, “Today was a very exciting day for everyone at SAIL and everyone involved in developing and backing our BowTie system. It is the culmination of decades of research into joint arthrodesis and years of hard work in response to countless surgeons telling us that they wanted a better solution to SI fusion. We look forward to completing our pilot study and launching the product in the United States in the near future.”
SAIL Fusion conducted the first implantations of its novel BowTie SI Fusion System. BowTie is reported to be the first SI fusion system to be based on long-standing joint fusion principles established by the AO Foundation. The technology and surgical technique are designed to minimize tissue disruption, thoroughly prepare the joint and provide...
SAIL Fusion conducted the first implantations of its novel BowTie SI Fusion System. BowTie is reported to be the first SI fusion system to be based on long-standing joint fusion principles established by the AO Foundation. The technology and surgical technique are designed to minimize tissue disruption, thoroughly prepare the joint and provide rigid fixation to enable true and robust arthrodesis.
The device features a novel bowtie shape and integrated iliac and sacral transfixing screws to maximize rigidity, as well as a proprietary porous structure and roughened surface technology to aid in osteointegration.
David Jansen, President & CEO of SAIL, commented, “Today was a very exciting day for everyone at SAIL and everyone involved in developing and backing our BowTie system. It is the culmination of decades of research into joint arthrodesis and years of hard work in response to countless surgeons telling us that they wanted a better solution to SI fusion. We look forward to completing our pilot study and launching the product in the United States in the near future.”
Copy to clipboard 
